Marin M L, Gordon R E, Veith F J, Tulchin N, Panetta T F
Division of Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY 10467.
J Vasc Surg. 1993 Aug;18(2):170-6; discussion 176-7.
Smooth muscle cell (SMC) proliferation is a central event in the development of arteriosclerotic plaque. Regulation of this proliferative process is controlled in part by the action of specific peptide growth factors that may influence early cell-cycle regulatory gene expression. Such "early" response genes include the protooncogene c-myc, which has been implicated in the induction of cell proliferation and differentiation. We compared the distribution of the c-myc protooncogene product in healthy and atherosclerotic human carotid arteries to determine its cellular and tissue localization.
Samples of six carotid artery plaques from six patients were rapidly frozen in liquid nitrogen at the time of carotid endarterectomy. Three nondiseased human carotid arteries obtained at organ harvest from brain-dead organ donors were similarly prepared. Frozen sections were labeled with a polyclonal rabbit anti-c-myc antibody that recognizes the 64 kd c-myc human protein. The percentages of cells positive for c-myc (c-myc index) and the intensity of antibody labeling were determined.
Normal human carotid artery demonstrated minimal, isolated cell staining, with single scattered grains of immunocytochemical staining product seen in SMC nuclei. The myc index was 14.7% +/- 3.5% positive cells. In comparison, SMCs from carotid plaque showed a significant predominance of c-myc immunoreactive cells (89.8% +/- 4%; p < 0.001). The intensity of c-myc staining was greater in plaque SMCs, with many of the cells demonstrating confluence of immunocytochemical precipitate throughout 50% of SMC nuclei.
Although the exact role of enhanced expression of the c-myc protooncogene in atherosclerosis is unclear, a cooperative influence of abnormal early cell-cycle gene expression and humoral factors may initiate the atherogenic process. The c-myc gene and other protooncogenes are early molecular markers of cell-cycle activity, which may be important in the development of atherosclerosis and occlusive vascular disease.
平滑肌细胞(SMC)增殖是动脉粥样硬化斑块形成过程中的核心事件。这一增殖过程的调控部分受特定肽生长因子的作用影响,这些生长因子可能影响早期细胞周期调控基因的表达。此类“早期”反应基因包括原癌基因c-myc,它与细胞增殖和分化的诱导有关。我们比较了c-myc原癌基因产物在健康和动脉粥样硬化的人类颈动脉中的分布,以确定其细胞和组织定位。
6例患者的6个颈动脉斑块样本在颈动脉内膜切除术时迅速在液氮中冷冻。从脑死亡器官供体获取的3个未患病的人类颈动脉也进行了类似处理。冰冻切片用识别64 kd人c-myc蛋白的多克隆兔抗c-myc抗体标记。测定c-myc阳性细胞的百分比(c-myc指数)和抗体标记强度。
正常人类颈动脉显示极少的、孤立的细胞染色,在SMC细胞核中可见单个散在的免疫细胞化学染色产物颗粒。myc指数为14.7%±3.5%阳性细胞。相比之下,颈动脉斑块中的SMC显示c-myc免疫反应性细胞显著占优势(89.8%±4%;p<0.001)。斑块SMC中c-myc染色强度更大,许多细胞在50%的SMC细胞核中显示免疫细胞化学沉淀物融合。
虽然c-myc原癌基因表达增强在动脉粥样硬化中的确切作用尚不清楚,但异常早期细胞周期基因表达和体液因子的协同影响可能启动动脉粥样硬化过程。c-myc基因和其他原癌基因是细胞周期活性的早期分子标志物,这在动脉粥样硬化和闭塞性血管疾病的发展中可能很重要。